Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

ANAB AnaptysBio Inc

26,58

0,24 (0,91%)

Nach Börsenschluss

Zuletzt aktualisiert: 22:33:53

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

AnaptysBio (NASDAQ:ANAB)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more AnaptysBio Charts.

AnaptysBio (NASDAQ:ANAB)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more AnaptysBio Charts.

News AnaptysBio Inc

Actym Therapeutics Appoints Thomas Smart as CEO
Mittwoch 24 April 2024 (1 Woche vor) • PR Newswire (US)

Form S-8 - Securities to be offered to employees in employee benefit plans
Montag 11 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Montag 11 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 11 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Anaptys to Present at TD Cowen’s 44th Annual Health Care Conference and 2024 AAD Annual Meeting
Donnerstag 29 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Anaptys to Present at Guggenheim’s 6th Annual Biotechnology Conference
Mittwoch 31 Januar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 10 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 10 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 5 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 5 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere AnaptysBio Inc News-Artikel

Deutsche Lufthansa

BNP Paribas (QX)

Invesco QQQ Trust Series 1

Health Care Select Sector

Financial Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen